Stockscreener 앱 받기
2.09
1.88%
-0.04
전일 마감가:
$2.13
열려 있는:
$2.205
하루 거래량:
6,487
Relative Volume:
0.11
시가총액:
$3.28M
수익:
$574.20K
순이익/손실:
$-11.52M
주가수익비율:
-0.0456
EPS:
-45.8332
순현금흐름:
$-6.92M
1주 성능:
-4.57%
1개월 성능:
+22.94%
6개월 성능:
+186.93%
1년 성능:
+465.17%
1일 변동 폭
$2.08
$2.205
1주일 범위
$2.00
$2.235
52주 변동 폭
$0.3107
$5.89
애틀론 메디컬 Stock (AEMD) Company Profile
명칭
Aethlon Medical Inc
전화
619-941-0360
주소
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Compare AEMD vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
2.09 | 3.28M | 574.20K | -11.52M | -6.92M | -45.83 |
ABT
Abbott Laboratories
|
101.83 | 176.95B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
332.07 | 127.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.42 | 110.95B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
61.86 | 91.93B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.84 | 46.61B | 6.07B | 1.06B | 1.34B | 1.8063 |
애틀론 메디컬 Stock (AEMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 재개 | H.C. Wainwright | Neutral |
애틀론 메디컬 주식(AEMD)의 최신 뉴스
What is the fair value of Aethlon Medical Inc. stock now2026 Sector Review & Technical Pattern Based Signals - Bollywood Helpline
Q3 2026 Aethlon Medical Inc Earnings Call Transcript - GuruFocus
Aethlon Medical Update: DSMB Clears Aussie Oncology Trial to Advance Hemopurifier to Cohort 3 - Defense World
Death Cross: How is Aethlon Medical Inc managing supply chain issues2026 Analyst Calls & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Aethlon Medical (AEMD) director forfeits 178 shares to cover RSU taxes - Stock Titan
Aethlon Medical (NASDAQ: AEMD) director forfeits 178 shares for tax withholding - Stock Titan
Director at Aethlon (NASDAQ: AEMD) forfeits shares to cover taxes - Stock Titan
Aethlon Medical : Corporate OverviewMarch 2026 - marketscreener.com
Performance Recap: Whats the profit margin of Aethlon Medical IncQuarterly Profit Report & High Accuracy Investment Entry Signals - baoquankhu1.vn
Aethlon Medical advances to final cohort in cancer device trial By Investing.com - Investing.com Australia
Market Pulse: How is Aethlon Medical Inc managing supply chain issuesWeekly Trend Report & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review - Bitget
AEMD Technical Analysis & Stock Price Forecast - Intellectia AI
Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2026 earnings call transcript - MSN
Advancements in Novel Immunotherapeutics in The Oncology Battle - The Globe and Mail
Cancer device study moves forward after reviewers find no safety issues - Stock Titan
Novel Immunotherapeutics Stocks in the News (Nasdaq:AEMD), (Nasdaq:HURA) (NYSE: AZN) (Nasdaq: ELTX) - Investorideas.com
AEMD Trial Progress: Aethlon Medical Advances to Final Cohort - GuruFocus
Medical Tech Stock Aethlon Medical, Inc. (NASDAQ: AEMD) Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review - Investorideas.com
Aethlon Medical advances to final cohort in cancer device trial - Investing.com
Aug Closing: Does Aethlon Medical Inc offer margin of safetyWatch List & Fast Moving Stock Watchlists - baoquankhu1.vn
If You Invested $1,000 in Aethlon Medical (AEMD) - Stock Titan
Aethlon Medical, Inc.: Fundamental Analysis and Financial Ratings | EJU0 | US00808Y5050 - marketscreener.com
OTC Markets Hosts Virtual Investor Presentation with Jim Frakes, CEO and CFO of Aethlon Medical, and M. Marin, Senior Analyst at Zacks SCR - Yahoo Finance
Aethlon Medical announces full exercise of pre-funded warrants By Investing.com - Investing.com India
Aethlon Medical announces full exercise of pre-funded warrants - Investing.com
Aethlon Medical, Inc. Announces All Pre-Funded Warrants Exercised; 1,569,110 Shares Outstanding as of March 16, 2026 - Minichart
Aethlon Medical Completes Pre-Funded Warrant Exercises, Simplifying Equity - TipRanks
All Aethlon Medical (AEMD) pre-funded warrants exercised, 1,569,110 shares out - Stock Titan
Aethlon Medical hires Maxim Group to explore strategic options - Investing.com Nigeria
Aethlon Medical hires Maxim Group to explore strategic options By Investing.com - Investing.com South Africa
Aethlon Medical at Life Sciences Forum: Hemopurifier’s Oncology Focus By Investing.com - Investing.com Canada
Medical Tech Stock Aethlon Medical, Inc. (NASDAQ: AEMD) Gains on News - Investorideas.com
Medical Tech Stock Aethlon Medical, Inc. (NASDAQ: AEMD) Engages Maxim Group LLC to Evaluate Strategic Opportunities - Investorideas.com
Aethlon Medical (AEMD) Explores Strategic Opportunities with Max - GuruFocus
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Cancer and infection treatment developer Aethlon explores deals with Maxim - Stock Titan
Aethlon Medical Q1 2026 Earnings Preview - MSN
Winners Losers: Is Aethlon Medical Inc showing insider buyingIPO Watch & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Investment Review: Whats the profit margin of Aethlon Medical IncPortfolio Value Report & Verified Short-Term Plans - baoquankhu1.vn
Aethlon Medical to Present at Life Sciences Investor Forum - Intellectia AI
Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th - GlobeNewswire
Energy Moves: Can Aethlon Medical Inc continue delivering strong returnsInsider Buying & Safe Capital Growth Trade Ideas - baoquankhu1.vn
AEMD SEC FilingsAethlon Medical 10-K, 10-Q, 8-K Forms - Stock Titan
Totaligent Executes Binding LOI for Joint Venture and Acquisition of GloMed Solutions - Benzinga
Aethlon Medical to Present at Emerging Growth Conference - Intellectia AI
Ask Aethlon Medical’s CEO and CFO live at Emerging Growth Conference - Stock Titan
Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026 - Yahoo Finance
Zacks Research Weighs in on Aethlon Medical FY2026 Earnings - Defense World
Can Aethlon Medical Inc. deliver consistent dividendsJuly 2025 Chart Watch & Fast Gaining Stock Reports - mfd.ru
FY2026 EPS Estimate for Aethlon Medical Decreased by Analyst - Defense World
애틀론 메디컬 (AEMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.44%
0.34%
자본화:
|
볼륨(24시간):